A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer

Lung Cancer

Volumn 45, Issue 1, 2004, Pages 57-65

  Dirkx, Maarten L P ^a   Van Sörnsen De Koste, John R ^a,b   Senan, Suresh ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Accelerated treatment; Chemo radiotherapy; Local tumour control; NSCLC; Simultaneous integrated boost

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CARDIOTOXICITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGUS; ESOPHAGUS DISEASE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG TOXICITY; LUNG VOLUME; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SPINAL CORD; SPINAL CORD DISEASE; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR REGRESSION; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT CARE PLANNING; RADIATION INJURIES; RISK FACTORS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 2942544339     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.01.003     Document Type: Article

References (38)

1. Arriagada R., Le Chevalier T., Quoix E., Ruffie P., de Cremoux H., Douillard J.Y., et al. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Federation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;1183-1190
2. Martel M.K., Ten Haken R.K., Hazuka M.B. Estimation of tumor control probability parameters from 3D dose distributions of non-small cell lung cancer patients. Lung Cancer. 24:1999;31-37
3. Fowler J.F., Chapell R. Non-small cell tumors repopulate rapidly during radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 46:2000;516-517
4. Schaake-Koning C., van den Bogaert W., Dalesio O., Festen J., Hoogenhout J., van Houtte P., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. New Engl. J. Med. 326:1992;524-530
5. Saunders M., Dische S., Barrett A., Harvey A., Griffiths G., Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from a randomised multicentre trial. Radiother. Oncol. 52:1999;137-148
6. Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, et al. ECOG 2597: Phase III study of induction chemotherapy followed by standard thoracic radiotherapy (STD TRT) vs hyperfractionated accelerated radiotherapy (HART) for patients with unresectable stage IIIA & B non-small cell lung cancer. Lung Cancer 2003;41:S39 (abstract O-125).
7. Pos F.J., van Tienhoven G., Hulshof C.C.M., Koedooder K., González González D. Concomitant boost radiotherapy for muscle invasive bladder cancer. Radiother. Oncol. 68:2003;75-80
8. Butler E.B., Teh B.S., Grant W.H. III, Uhl B.M., Kuppersmith R.B., Chiu J.K., et al. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 45:1999;21-32
9. Fu K.K., Pajak T.F., Trotti A., Jones C.U., Spencer S.A., Phillips T.L., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 48:2000;7-16
10. Bos L.J., Damen E.M.F., de Boer R.W., Mijnheer B.J., McShan D.L., Fraass B.A., et al. Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. Int. J. Radiat. Oncol. Biol. Phys. 52:2002;254-265
11. Emami B., Perez C.A., Herskovich A., Hederman M.A. Phase I/II study of treatment of locally advanced (T3T4) non-oat cell lung cancer with high dose radiotherapy (rapid fractionation): radiation therapy oncology group study. Int. J. Radiat. Oncol. Biol. Phys. 15:1988;1021-1025
12. Graham M.V., Pajak T.E., Herskovic A.M., Emami B., Perez C.A. Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): long-term results. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;819-825
13. King S.C., Acker J.C., Kussin P.S., Marks L.B., Weeks K.J., Leopold K.A. High-dose, hyperfractionated accelerated radiotherapy using a concurrent boost for the treatment of non-small cell lung cancer: unusual toxicity and promising early results. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;593-599
14. Uitterhoeve A.L.J., Belderbos J.S.A., Koolen M.G.J., van der Vaart P.M.J., Rodrigus P.T.R., Benraadt J., et al. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. Eur. J. Cancer. 36:2000;592-600
15. Senan S., Burgers S., Samson M.J., van Klaveren R.J., Oei S.S., van Sörnsen de Koste J., et al. Can elective nodal irradiation be omitted in stage III non-small cell lung cancer? An analysis of recurrences in a phase II study of induction chemotherapy and 'involved-field' radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 54:2002;999-1006
16. Lagerwaard F.J., van Sörnsen de Koste J.R., Nijssen-Visser M.R.J., Schuchhard-Schipper R.H., Oei S.S., Munne A., et al. Multiple 'slow' CT scans for incorporating lung tumor mobility in radiotherapy planning. Int. J. Radiat. Oncol. Biol. Phys. 51:2001;932-937
17. Lagerwaard F.J., van de Vaart P., Voet P.W.J., Schuchhard-Schipper R.H., Joosten H.P.J., Oei S.S., et al. Can errors in reconstructing pre-chemotherapy volumes contribute to the inferiority of sequential chemoradiation in stage III non-small lung cancer (NSCLC)? Lung Cancer. 38:2002;297-301
18. Van Sörnsen de Koste J.R., Voet P., Dirkx M., van Meerbeeck J.P., Senan S. An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer. Lung Cancer. 32:2001;145-153
19. Stroom J.C., Storchi P.R.M. Automatic calculation of three-dimensional margins around treatment volumes in radiotherapy planning. Phys. Med. Biol. 42:1997;745-753
20. BJR Supplement 25 Central axis depth dose data for use in radiotherapy: 1996. London: the Institute of Radiology, 1996.
21. Maciejewski B., Withers H.R., Taylor J.M.G., Hliniak A. Dose fractionation and regeneration for cancer of the oral cavity and oropharynx: tumor-dose response and repopulation. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;831-843
22. Kwa S.L.S., Lebesque J.V., Theuws J.C.M., Marks L.B., Munley M.T., Bentel G., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int. J. Radiat. Oncol. Biol. Phys. 42:1998;1-9
23. Mohan R., Wu Q., Manning M., Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 46:2000;619-630
24. Graham M.V., Purdy J.A., Emami B., Matthews J.W., Harms W.B. Preliminary results of a prospective trial using three-dimensional radiotherapy for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;993-1000
25. Maguire P.D., Sibley G.S., Zhou S.M., Jamieson T.A., Light K.L., Antoine P.A., et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int. J. Radiat. Oncol. Biol. Phys. 45:1999;97-103
26. Burman C., Kutcher G., Emami B., Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;123-136
27. Martel M.K., Sahijdah W.M., ten Haken R.K., Kessler M.L., Turrisi A.T. Fraction size and dose parameters related to the incidence of pericardial effusions. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;155-161
28. Ataman O.U., Bentzen S.M., Saunders M.I., Dische S. Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: a competing risks analysis. Br. J. Cancer. 85:2001;1113-1118
29. Jenkins P., D'Amico K., Benstead K., Elyan S. Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART). Int. J. Radiat. Oncol. Biol. Phys. 56:2003;360-366
30. Emamia B., Mirkovic N., Scott C., Byhardt R., Graham M.V., Andras E.J., et al. The impact of regional nodal radiotherapy (dos/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data. Lung Cancer. 41:2003;207-214
31. Arriagada R. Optimizing chemotherapy and radiotherapy in locally advanced non-small cell lung cancer. Hematol. Oncol. Clin. N. Am. 11:1997;461-472
32. Hayman J.A., Martel M.K., Ten Haken R.K., Normolle D.P., Todd R.F. III, Littles J.F., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J. Clin. Oncol. 19:2001;127-136
33. Rosenman J.G., Halle J.S., Socinski M.A., Deschesne K., Moore D.T., Johnson H., et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. Int. J. Radiat. Oncol. Biol. Phys. 54:2002;348-356
34. Mehta M., Scrimger R., Mackie R., Paliwal B., Chapell R., Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 49:2001;23-33
35. Rosenman J.G., Miller E.P., Tracton G., Cullip T.J. Image registration: an essential part of radiation therapy treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;197-205
36. Yu C.X., Jaffray D.A., Wong J.W. The effects of intra-fraction organ motion on the delivery of dynamic intensity modulation. Phys. Med. Biol. 43:1998;91-104
37. Rosenzweig K.E., Hanley J., Mah D., Braban L.E., Schindelheim R., Leibel S.A. The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 48:2000;81-87
38. Wong J.W., Sharpe M.B., Jaffray D.A., Kini V.R., Robertson J.M., Stromberg J.S., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int. J. Radiat. Oncol. Biol. Phys. 44:1999;911-919